HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

BACKGROUND: Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. There are promising results using prophylactic HIPEC in this group of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjona-Sánchez, A., Barrios, P., Boldo-Roda, E., Camps, B., Carrasco-Campos, J., Concepción Martín, V., García-Fadrique, A., Gutiérrez-Calvo, A., Morales, R., Ortega-Pérez, G., Pérez-Viejo, E., Prada-Villaverde, A., Torres-Melero, J., Vicente, E., Villarejo-Campos, P., Sánchez-Hidalgo, J. M., Casado-Adam, A., García-Martin, Ruben, Medina, Manuel, Caro, T., Villar, C., Aranda, Enrique, Cano-Osuna, M. T., Díaz-López, C., Torres-Tordera, E., Briceño-Delgado, F. J., Rufián-Peña, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812226/
https://www.ncbi.nlm.nih.gov/pubmed/29439668
http://dx.doi.org/10.1186/s12885-018-4096-0

Ejemplares similares

Ejemplares similares